Stevens Capital Management LP Galapagos Nv Transaction History

Stevens Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$146.12 - $215.82 $282,742 - $417,611	-1,935 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$130.44 - $187.64 $252,401 - $363,083	1,935 New	1,935 $295,000
Q2 2019 Jul 31, 2019	SELL	$111.45 - $128.93 $377,035 - $436,170	-3,383 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$89.61 - $117.78 $303,150 - $398,449	3,383 New	3,383 $398,000

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.74B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.